Photodynamic therapy for CIN3
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests a light-based treatment called photodynamic therapy for women with moderate to severe cervical changes (CIN3). It aims to destroy abnormal cells while saving healthy tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with CIN3 and want to try photodynamic therapy
- Your cervix has a type 1 or type 2 transformation zone that the doctor can see fully with a colposcope
- The edges of the abnormal area are clearly visible
- A sample from deeper in the cervix (ECC) did not show high-grade changes
- You do not have porphyria or an allergy to red or blue light
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a light-based treatment (photodynamic therapy) for high-grade or persistent low-grade abnormal cells in the cervix or vagina. It aims to destroy these cells without surgery, which may be an option for patients who want to avoid more invasive procedures.
This study tests a light-based treatment called photodynamic therapy for cervical pre-cancer (CIN2). It may help remove abnormal cells while avoiding more invasive surgery, and aims to see if this treatment is safe and works well.
This trial tests a light-activated therapy (called HAL-PDT) for a specific type of abnormal cervical cell change known as CIN2. It aims to see if this treatment can destroy the abnormal cells while keeping the cervix healthy, potentially avoiding surgery.
This trial tests a light-based treatment (photodynamic therapy) for high-grade cervical precancerous changes, which may avoid the need for immediate surgery. It compares this approach to standard surgery to see if it is safe and effective.
This study tests a light-based treatment called ALA-PDT to see if it can help clear precancerous cervical changes caused by HPV types 16 or 18. It may be an option to avoid more invasive procedures.
This study is testing a new, non-invasive way to screen for cervical cancer using light-based detection and epigenetic analysis. It may help find high-risk changes earlier and more accurately than current methods.
Hear when a new Precancerous Cervical Lesion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.